Business · 01/08/2005Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Enrofloxacin for Poultry Use
Summary
The US Food and Drug Administration (FDA) is removing the approval of a new animal drug application (NADA) for enrofloxacin, a medication used to treat poultry, due to its withdrawal of approval. Bayer Corp. sponsored the application, which was NADA 140-828.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →